NCT05703672View on ClinicalTrials.gov

Switching to E-cigarettes in African-American Smokers

PHASE3RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

February 1, 2027

Conditions
Smoking Reduction
Interventions
DRUG

Varenicline Tartrate

0.5 mg once daily for days 1-3, 0.5mg twice daily for days 4-7 and 1.0 mg twice daily from day 8 through week 12.

DRUG

Placebo

One pill (white) once daily for days 1-3, one pill (white) twice daily for days 4-7 and one pill (blue) twice daily from day 8 through week 12.

OTHER

Electronic cigarette

Nicotine salt pod based e-cigarette in 5% nicotine

Trial Locations (2)

64130

RECRUITING

Swope Health Central, Kansas City

RECRUITING

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER